AKT1 and Insulin resistance: Additionally, GABA activates the PI3K/AKT pathway (phosphoinositide 3-kinase/protein kinase B), enhancing the expression of insulin receptor substrate 1 (IRS1) and GLUT4, thereby boosting insulin sensitivity and reducing homeostatic model assessment for insulin resistance (HOMA-IR) [76,77].